Co-Authors
This is a "connection" page, showing publications co-authored by Saskia Middeldorp and Hugo Ten Cate.
Connection Strength
0.339
-
The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients. Thromb Res. 2018 10; 170:75-83.
Score: 0.195
-
Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysis. Lancet Haematol. 2018 Nov; 5(11):e512-e519.
Score: 0.049
-
Clinical and economic impact of compression in the acute phase of deep vein thrombosis. J Thromb Haemost. 2018 Jun 01.
Score: 0.048
-
Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial. Lancet Haematol. 2018 Jan; 5(1):e25-e33.
Score: 0.047